ArticleJournal of cardiovascular imaging2026
Low- versus high-concentration iodine contrast media for coronary computed tomography angiography and dynamic stress computed tomography perfusion: a study protocol for a prospective randomized trial.
Article in Journal of cardiovascular imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis prospective randomized study protocol is designed to determine whether low-concentration iodine contrast media can maintain coronary enhancement on coronary computed tomography angiography (CCTA) compared with high-concentration iodine contrast media under standardized acquisition conditions. Dynamic stress computed tomography perfusion (CTP)-derived myocardial blood flow (MBF) will be assessed as a key secondary quantitative endpoint. Exploratory diagnostic performance analyses using invasive coronary angiography (ICA) and fractional flow reserve (FFR) will be performed only in clinically indicated invasive testing subgroups.
methodsThe trial plans to enroll 258 adults (age ≥ 40 years) with known or suspected coronary artery disease referred for clinically indicated cardiac computed tomography, including CCTA with planned dynamic stress CTP. Participants will be randomized 1:1 to receive low-concentration iodine contrast media (270 mg I/mL) or high-concentration iodine contrast media (350 mg I/mL). The primary endpoint is quantitative coronary enhancement on CCTA. Dynamic stress CTP-derived MBF will be evaluated as a key secondary endpoint focused on quantitative comparability. ICA/FFR-based diagnostic performance analyses will be considered prespecified exploratory analyses in participants who undergo invasive testing as part of routine clinical care. The primary endpoint will be analyzed using linear mixed-effects models with a prespecified noninferiority margin, and MBF will be analyzed using mixed-effects models without claiming formal equivalence or noninferiority. DISCUSSION: This study protocol is expected to clarify whether low-concentration iodine contrast media can maintain CCTA coronary enhancement and support quantitative dynamic stress CTP assessment while reducing iodine exposure. Because ICA and FFR are clinically driven rather than protocol mandated, diagnostic performance analyses will be interpreted cautiously and regarded as exploratory.
trial registrationCRIS identifier: KCT0011418. Registered on January 7, 2026.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.